What Happened? Shares of biotech company Vertex Pharmaceuticals (NASDAQ: VRTX) jumped 3.8% in the afternoon session after Wolfe Research upgraded the stock from "Peer Perform" to "Outperform" and issued a $548 price target. The analyst firm pointed to a changing outlook for the company's potential... read full story